BOM-ZEN: Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy

Sponsor
University Hospital, Caen (Other)
Overall Status
Completed
CT.gov ID
NCT04168983
Collaborator
(none)
90
1
2
24
3.7

Study Details

Study Description

Brief Summary

The bone marrow aspiration and biopsy (BMAB) is an essential and indispensable examination for the diagnosis and the follow-up of the hematological diseases but which remains painful and dread by the patients. Until then it was performed manually using a trocar. It is now practiced most often using a tool (like a small drill), device that pierces through the external iliac bone to extract a bone cylinder that will be analyzed

If the gesture is faster than with the manual method, it remains overall painful and the noise generated by the drill that passes through the periosteum of the iliac bone is impressive for the patient.

Prevention measures to limit pain and anxiety are put in place during the examination: local anesthesia, with or without a lidocaine patch, as well as inhalation of a mixture of nitrous oxide and oxygen (MEOPA®). These, recommended by the "Standards, Options, Recommendation" (SOR) often remain insufficient and are not devoid of undesirable effects.

Despite these precautions, several studies show that the action remains painful and anxiety-provoking.

An exploratory survey carried out in the hematology department of the François Baclesse Center in 2013 confirms these results and specifies that the pain remains present for another 30 minutes after the examination.

The investigators believe that associating a psycho-corporeal technique, as is sophrology, with the usual care, could contribute to the decrease of the threshold of pain and anxiety during the BMAB and avoid the use of a premedication.

The effectiveness of sophrology as a complementary technique in the field of pain prevention in invasive procedures is recognized by observations and clinical results. This complementary therapy, among others, has its place in the hospital.

To date, to investigator's knowledge, there is no published, randomized study evaluating the effectiveness of sophrology on pain in invasive procedures.

The investigators propose a study whose main objective is to evaluate the effectiveness of a session of sophrology on the pain felt during the realization of the BMAB, in patients with hematological malignancy. This session will be provided by a sophrologist nurse This study should include 90 patients undergoing a BMAB over a 24-month period.

Condition or Disease Intervention/Treatment Phase
  • Other: sophrology
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Single centre, comparative, controlled randomized studySingle centre, comparative, controlled randomized study
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Study of the Impact of Sophrology on the Pain Felt During a Bone Marrow Aspiration and Biopsy
Actual Study Start Date :
Sep 25, 2019
Actual Primary Completion Date :
Sep 25, 2021
Actual Study Completion Date :
Sep 25, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Usual care: local anesthesia + nitrous oxide and oxygen administration

Experimental: Experimental

Usual care: local anesthesia + nitrous oxide and oxygen administration In this arm : sophrology is added

Other: sophrology
Sophrology session provided by a nurse sophrologist in addition to the usual care during BMAB

Outcome Measures

Primary Outcome Measures

  1. Visual analog scale (VAS) score of the pain felt by the patient during the gesture of performing the BMAB [Baseline]

    This is a self-assessment. This scale has two sides. On one side, the patient identifies his pain with a ruler, left (no pain) right (the strongest pain he has ever felt). On the other hand, the caregiver raises the corresponding score from 0 to 10. Pain will bemeasured a posteriori (not possible to evaluate during the sophrology sesssion)

Secondary Outcome Measures

  1. Numerical score (NS) of anxiety of the patient before the BMAB [Baseline]

    The same scale is used to measure anxiety

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient over 18 years old who has been informed of the study and has signed the consent form of the study

  • Patient with a malignant hemopathy requiring a BMAB as part of a diagnostic assessment

  • Patient who has never had a BMAB before

  • Patient affiliated to a social security scheme

Exclusion Criteria:
  • Patient requiring oral premedication

  • Patient with contraindications or intolerance to MEOPA®

  • Patient with a history of allergy to local anesthetics

  • Patient not understanding French

  • Patient with deafness

  • Patient with severe cognitive impairment

  • Patient under legal protection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Caen University Hospital Caen France 14033

Sponsors and Collaborators

  • University Hospital, Caen

Investigators

  • Principal Investigator: Brigitte Touchet, University Hospital, Caen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT04168983
Other Study ID Numbers:
  • 2019-A00796-51
First Posted:
Nov 19, 2019
Last Update Posted:
Mar 3, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2022